EL7.AI
StocksMedium•27 October 2026•
3 min read

SUSS Reaffirms 2026 Sales Guidance at €425–485 Million Despite First-Half Revenue Decline

Key Facts

1SUSS reaffirmed 2026 sales guidance at €425–485 million, gross margin at 35–37% and EBIT margin at 8–10%.
2Group sales totaled €202.8 million in the first half of 2026, compared with €266.6 million in the same period of 2025.
3Orders received reached €410.0 million in the first half, including €260.7 million in the second quarter.
4The order backlog reached a record €473.7 million on June 30, 2026.
5The company set November 5, 2026, as the date for publishing its third-quarter statement.

In its half-year report published on August 6, 2026, SUSS MicroTec reaffirmed its guidance for the fiscal year, setting sales at €425 million to €485 million, gross margin at 35% to 37% and EBIT margin at 8% to 10%. The reaffirmation puts management’s official ranges at the center of the company’s financial outlook as first-half data showed sales declining from the same period a year earlier. Group sales totaled €202.8 million in the first six months of 2026, compared with €266.6 million in the first half of 2025. At the same time, new orders flowed in strongly during the period, highlighting the gap between orders being booked and turning into actual sales. The available official figures show the company’s guidance as reaffirmed in August, without establishing that it was cut on October 27 or that the stock fell 10% on that date.

Orders received totaled €410.0 million in the first half, after the second quarter alone set a record of €260.7 million. The company said, "Orders received reached a new record level of €260.7 million in the second quarter," adding that the first-half total rose to €410.0 million. This reflects the strength of new business flowing into the company’s order book during the period, but orders do not become revenue as soon as they are booked; the timing of their contribution to sales depends on project completion and equipment delivery. The order backlog reached a record €473.7 million on June 30, 2026, representing the company’s accumulated business on that date. This provides important context for future sales, while execution of orders and delivery schedules remain factors affecting when they are recognized.

Under the delivery schedule in place when the company reported in August, about €220 million of the order backlog was due to be converted into sales in 2027. The schedule indicates that a large portion of booked business is not included in current-year sales but is linked to later deliveries. SUSS said supplier bottlenecks could mean delays in equipment completion and delivery could not be entirely ruled out. At the same time, it said its current guidance does not assume major project delays. The company said, "Delays in equipment completion and delivery can no longer be entirely ruled out at SUSS either," while emphasizing that its guidance currently does not assume major delays. This caveat remains part of the outlook, as any delivery delay could affect when orders convert into sales.

According to the analyst estimates page published by SUSS, the average analyst estimate for fiscal 2026 sales was about €464.1 million, with an average EBIT margin of 9.7%, in an update dated October 9. The sales estimate is within management’s range of €425–485 million, and the average EBIT margin is also within the company’s range of 8–10%. These are analyst estimates compiled by the company, not a revision to management’s guidance; SUSS reaffirmed its annual ranges in its August first-half report. This comes against a backdrop of first-half sales below the year-earlier period, offset by a high level of orders and a record order backlog. The company is scheduled to publish its quarterly statement covering third-quarter results on November 5, 2026, its next scheduled update to the market on its performance.